Archive

[Webinar] Marijuana to Schedule III: What Changes, What Doesn’t, and What Comes Next

Dec 22, 2025

Vicente LLP’s national cannabis policy team hosted a live session on the federal move to reclassify marijuana from Schedule I to Schedule III, which marks the most significant shift in cannabis policy in more than 50 years. In this webinar, our attorneys break down the changes to Schedule III rescheduling, what remains unchanged, and what comes next as the federal rulemaking process moves forward. The session will examine the anticipated federal timeline, potential litigation risks, and the ripple effects for state-legal cannabis programs, taxation, medical research and patient access, banking, and the hemp and cannabinoid marketplace.

Cannabis Rescheduling Explained

By Shawn Hauser, Juliana Todeschi, Charles Alovisetti, Cassia Furman
Dec 18, 2025

In this comprehensive guide, Vicente LLP breaks down federal cannabis rescheduling under the Controlled Substances Act, explores what Schedule III means for taxes, research, banking, and outlines what changes and what does not under federal law.

[Webinar] Federal Hemp Ban Explained: A State-by-State Analysis & 2026 Outlook with Vicente LLP

Dec 10, 2025

States across the country are preparing to respond to the new federal definition of hemp—and the ripple effects could reshape the regulatory landscape for hemp-derived products in 2026. In this session, we break down how federal changes interact with state trigger laws, controlled-substances updates, and emerging regulatory frameworks. Our attorneys will outline which jurisdictions may see the biggest shifts, how state processes could impact product categories and operations, and what businesses should monitor in the year ahead, supported by a state-by-state overview of anticipated responses. Register now!

Vicente LLP at MJBizCon 2025: Leading Conversations on Tribal Sovereignty, Psychedelic Regulation & Minnesota’s Emerging Cannabis Market

Nov 22, 2025

Vicente LLP will take the stage at MJBizCon 2025 with director of economics and market analysis Andrew Livingston discussing Indigenous cannabis sovereignty, partner Jason Tarasek presenting on Minnesota’s adult-use rollout and business opportunities, and founding partner Joshua Kappel covering compliance, ethics, and best practices for psychedelics operators. Partners David Ullian and Cassia Furman will also be in attendance. Reach out to schedule a meeting with our team while you’re there!

Federal Hemp Policy Briefing: Critical Insights on the New Hemp Definition, THC Limits, and 2026 Market Impacts

Nov 19, 2025

Vicente LLP delivers a rapid-fire update on the sweeping federal changes redefining “hemp” and their impact on products, businesses, and state regulatory frameworks. We’ll break down the new Total THC limits, synthetic cannabinoid prohibitions, and one-year compliance timeline, as well as how these developments intersect with state “trigger” laws and potential cannabis rescheduling.

2025 Federal Hemp Reclassification: Congress Moves to Redefine “Hemp” and Ban Most Hemp-Derived THC Products

By Cassia Furman, Shawn Hauser, Juliana Todeschi, Bridgette Nikisher
Nov 13, 2025

A new federal law has been signed, effectively banning most commercially available hemp products. Language included in the FY2026 Agricultural Appropriations Bill resets the threshold for federally legal hemp at 0.3% Total THC, as opposed to delta-9 THC, caps Total THC content for finished products at 0.4 mg per container, and prohibits synthetic or converted cannabinoids such as delta-8 THC. In this blog, we break down the key aspects of the legislation, including how it changes the definition of hemp, the timelines businesses should prepare for, and what this means for hemp operators, manufacturers, distributors, and retailers nationwide.

Vicente LLP Earns Top National Recognition for Cannabis and Psychedelics Law in Chambers USA 2025 Guide

Jun 5, 2025

Vicente LLP is proud to once again earn Band 1 Nationwide rankings for both Cannabis Law and Psychedelics Law in the Chambers USA 2025 Guide—reaffirming our position as the leading firm in these emerging sectors. Since the introduction of Cannabis Law in 2019 and Psychedelics Law in 2024, we’ve consistently led the field with a proven track record, bold policy leadership, and a steadfast commitment to our clients.

[Webinar] Cannabis Real Estate Considerations

Oct 12, 2021

Watch this recorded session where members of VS’s real estate practice discuss cannabis real estate issues, including lease considerations, financing, and local jurisdiction laws that may affect your business. 

What is a Cannabis REIT?

By Charles Alovisetti, Cassia Furman
Apr 23, 2021

To many in the cannabis industry, REIT is not a common acronym. Yet, as cannabis businesses seek ways to raise funds, REITs are coming up in more and more conversations.